201 related articles for article (PubMed ID: 9361684)
21. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
22. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells.
Dagher Z; Ruderman N; Tornheim K; Ido Y
Circ Res; 2001 Jun; 88(12):1276-82. PubMed ID: 11420304
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.
King KL; Okere IC; Sharma N; Dyck JR; Reszko AE; McElfresh TA; Kerner J; Chandler MP; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1033-7. PubMed ID: 15821035
[TBL] [Abstract][Full Text] [Related]
24. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes.
Krause U; Bertrand L; Hue L
Eur J Biochem; 2002 Aug; 269(15):3751-9. PubMed ID: 12153572
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise.
Winder WW; Hardie DG
Am J Physiol; 1996 Feb; 270(2 Pt 1):E299-304. PubMed ID: 8779952
[TBL] [Abstract][Full Text] [Related]
26. Malonyl CoA control of fatty acid oxidation in the ischemic heart.
Dyck JR; Lopaschuk GD
J Mol Cell Cardiol; 2002 Sep; 34(9):1099-109. PubMed ID: 12392882
[TBL] [Abstract][Full Text] [Related]
27. Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells.
Fediuc S; Gaidhu MP; Ceddia RB
J Lipid Res; 2006 Feb; 47(2):412-20. PubMed ID: 16304351
[TBL] [Abstract][Full Text] [Related]
28. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
29. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids.
Clark H; Carling D; Saggerson D
Eur J Biochem; 2004 Jun; 271(11):2215-24. PubMed ID: 15153111
[TBL] [Abstract][Full Text] [Related]
30. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.
Folmes CD; Clanachan AS; Lopaschuk GD
Circ Res; 2006 Jul; 99(1):61-8. PubMed ID: 16741157
[TBL] [Abstract][Full Text] [Related]
31. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
Kantor PF; Lucien A; Kozak R; Lopaschuk GD
Circ Res; 2000 Mar; 86(5):580-8. PubMed ID: 10720420
[TBL] [Abstract][Full Text] [Related]
32. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.
Saha AK; Avilucea PR; Ye JM; Assifi MM; Kraegen EW; Ruderman NB
Biochem Biophys Res Commun; 2004 Feb; 314(2):580-5. PubMed ID: 14733947
[TBL] [Abstract][Full Text] [Related]
33. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.
Park H; Kaushik VK; Constant S; Prentki M; Przybytkowski E; Ruderman NB; Saha AK
J Biol Chem; 2002 Sep; 277(36):32571-7. PubMed ID: 12065578
[TBL] [Abstract][Full Text] [Related]
34. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats.
Atkinson LL; Kelly SE; Russell JC; Bar-Tana J; Lopaschuk GD
Diabetes; 2002 May; 51(5):1548-55. PubMed ID: 11978655
[TBL] [Abstract][Full Text] [Related]
35. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
[TBL] [Abstract][Full Text] [Related]
36. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
37. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase.
Rasmussen BB; Winder WW
J Appl Physiol (1985); 1997 Oct; 83(4):1104-9. PubMed ID: 9338417
[TBL] [Abstract][Full Text] [Related]
38. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
[TBL] [Abstract][Full Text] [Related]
39. Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle.
Vavvas D; Apazidis A; Saha AK; Gamble J; Patel A; Kemp BE; Witters LA; Ruderman NB
J Biol Chem; 1997 May; 272(20):13255-61. PubMed ID: 9148944
[TBL] [Abstract][Full Text] [Related]
40. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]